Purchase Order 75D30126P21232

The Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $57,490.00 firm fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, for-profit small disadvantaged business, for the procurement of NOVAPLEX HPV28 DETECTION KITS. The award has an ultimate completion date of May 30, 2025 and supports the CDC's public health mission related to HPV screening and prevention. This order follows previous contract awards to Seegene USA Inc. Sales Division for...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $72,000 firm-fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned for-profit small business, for the provision of SEEGENE NOVAPLEX molecular diagnostic reagents and associated products. This award supports the CDC's public health mission related to advancement of human papillomavirus (HPV) screening and prevention. The contract does not have a set-aside designation and there...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...

The Centers for Disease Control and Prevention, Pittsburgh issued a purchase order to Illumina, Inc. for $90,260.40 on July 26, 2021, with ultimate completion on September 8, 2026. No small business set-aside was used. Work is performed at Illumina's San Diego, California facility. The order procures sequencing reagents, consumables, or related biotechnology products under firm fixed price terms. This purchase order represents routine commercial procurement from a sole-source supplier of...

<p>The CDC Pittsburgh awarded a purchase order to Illumina, Inc. for lab equipment valued at $197,052.50 on August 11, 2022, with an ultimate completion date of August 31, 2027. No set-aside was used. Performance occurs in San Diego, California. The procurement is firm fixed price and covers DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software under Executive Order 14398.</p>

<p>The CDC Pittsburgh awarded a purchase order to Illumina, Inc. for a MiSeq System valued at $93,529.00 on August 19, 2024, with ultimate completion October 16, 2026. Place of performance is Fort Collins, Colorado. The order is firm fixed price with no set-aside applied, issued under Executive Order 14398.</p>

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...

The CDC Pittsburgh awarded a $29,595.03 firm fixed-price purchase order to Illumina, Inc. on August 9, 2024, for NextEra XT Library Preparation kits and related reagent supplies required for the agency's validated MiSeq Next-Generation Sequencing (NGS) assay. This assay supports the identification of HIV genetic mutations associated with drug resistance—a critical capability for HIV surveillance and treatment optimization. The contract, which carries no set-aside designation, will be performed...

<p>The Centers for Disease Control and Prevention (CDC) Pittsburgh issued a purchase order to Biosearch Technologies, Inc. for $40,367.80 on February 27, 2027, for GMP Influenza A Primer Kit supply. Place of performance is Atlanta, Georgia. The order carries a firm fixed price and completes on February 27, 2027. No set-aside applies.</p>